The detection of breast cancer has been an ongoing effort and unfortunate tragedy for now over three thousand women every month dying from breast cancer. For women over the age of thirty-four, breast cancer has been plagued as the leading cause of death. Living in a world with leading technological advances, why is such an epidemic unsolved for the masses? Cancer in itself among western medicine practices have seen its gradual advances over the years, although within the scope of breast cancer practices, there are still inefficiencies that lie given mammograms are still the primary practice to detect any preliminary stages of breast cancer.

Women are instructed to get checked regularly with screened mammograms to help lower the risk of breast cancer, but what many women do not know is that mammograms become 50% less effective when tested amongst dense breasts. Studies show that 10% of women have extremely dense breast tissue, resulting in what can be faulty testing during the mammogram in what may result in the patient receiving a “Happy Gram”. The current pain point and solution to this problem is to develop a non invasive, quick and safe procedure that can detect beyond the 5-10mm breast density to secure a much more sophisticated and accurate report. Leading innovators in this field are advancing this practice with companies such as SonoCiné AWBUS®, an effective technology platform designed to find virtually all 5-10mm breast cancers, including lobular and DCIS.

“I have been using SonoCiné for the past 4 years and have detected many cancers as small as 3mm. Fortunately with the cancer detected so early, none of my patients had to endure the next steps of invasive chemotherapy or radiation. It was as simple as getting a lumpectomy and going straight home.. this is the future of breast imaging.”